Remedy Entertainment Oyj
OMXH:REMEDY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Remedy Entertainment Oyj
OMXH:REMEDY
|
FI |
|
A
|
Advanced Micro Devices Inc
XETRA:AMD
|
US |
|
B
|
Bloober Team SA
WSE:BLO
|
PL |
|
DG Innovate PLC
LSE:DGI
|
UK |
|
F
|
Fantagio Corp
KOSDAQ:032800
|
KR |
|
I
|
Immuneering Corp
NASDAQ:IMRX
|
US |
|
P
|
PB Bankshares Inc
NASDAQ:PBBK
|
US |
|
Chenming Electronic Technology Corp
TWSE:3013
|
TW |
|
UMS Holdings Ltd
SGX:558
|
SG |
|
Gr Sarantis SA
OTC:SRTSF
|
GR |
|
Shandong Longquan Pipeline Engineering Co Ltd
SZSE:002671
|
CN |
|
I
|
Interwood Xylemboria ATENE
ATHEX:XYLEK
|
GR |
|
I
|
Inepar SA Industria e Construcoes
BOVESPA:INEP4
|
BR |
|
M
|
MX Gold Corp
XTSX:MXL.H
|
CA |
|
N
|
NEXR Technologies SE
XETRA:NXR
|
DE |
|
Dropsuite Ltd
ASX:DSE
|
AU |
Wall Street
Price Targets
REMEDY Price Targets Summary
Remedy Entertainment Oyj
According to Wall Street analysts, the average 1-year price target for REMEDY is 17.85 EUR with a low forecast of 16.16 EUR and a high forecast of 19.95 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is REMEDY's stock price target?
Price Target
17.85
EUR
According to Wall Street analysts, the average 1-year price target for REMEDY is 17.85 EUR with a low forecast of 16.16 EUR and a high forecast of 19.95 EUR.
What is Remedy Entertainment Oyj's Revenue forecast?
Projected CAGR
11%
For the last 9 years the compound annual growth rate for Remedy Entertainment Oyj's revenue is 15%. The projected CAGR for the next 3 years is 11%.
